Clinical Trial Update: Biomarkers to Detect Endocrine Therapy Resistance [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update focused on identifying biomarkers to detect resistance to endocrine therapy in metastatic breast cancer, including lobular carci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lobular Breast Carcinoma

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Metastatic Cancer, Breast Cancer | Phase 2 | Status: RECRUITING